ESOPHAGEAL CANCER
Clinical trials for ESOPHAGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cancer drug trial halted after early testing
Disease control TerminatedThis early-stage study tested the safety and highest tolerable dose of an experimental drug called INCB062079 in people with advanced liver cancer and other solid tumors. The trial enrolled 25 participants whose cancers had progressed after standard treatments and was designed to…
Matched conditions: ESOPHAGEAL CANCER
Phase: PHASE1 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Terminated trial tests new drug duo for Tough-to-Treat cancers
Disease control TerminatedThis study tested a new drug, PRT3789, combined with an existing immunotherapy (pembrolizumab) for people with advanced or spreading cancers that have a specific genetic change called a SMARCA4 mutation. The goal was to see if this combination was safe and could shrink or control…
Matched conditions: ESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Robot surgeons vs. big cuts: new hope for esophageal cancer patients?
Disease control TerminatedThis study aimed to test a new, less invasive robotic surgery technique for removing esophageal cancer tumors. It compared this new method, which uses a special dye to help guide the surgeon, against the traditional major open-chest surgery. The goal was to see if the robotic app…
Matched conditions: ESOPHAGEAL CANCER
Phase: NA • Sponsor: St. Joseph's Healthcare Hamilton • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Could delaying food after cancer surgery help patients recover stronger?
Disease control TerminatedThis study tested whether waiting a few days to start feeding patients after esophageal cancer surgery, instead of feeding them right away, might help preserve their muscle strength and improve recovery. Researchers compared two groups of patients to see if delayed feeding led to…
Matched conditions: ESOPHAGEAL CANCER
Phase: NA • Sponsor: University Hospital, Gasthuisberg • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
Targeted drug tested for tough cancers with rare genetic flaw
Disease control TerminatedThis study tested whether the drug niraparib could help control advanced solid tumors in patients whose cancer has a specific genetic change called a PALB2 mutation. It involved 22 adults with various cancers (like breast, lung, or pancreatic) that had spread or were locally adva…
Matched conditions: ESOPHAGEAL CANCER
Phase: PHASE2 • Sponsor: Tempus AI • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New cancer drug trial tests immune system booster for tough tumors
Disease control TerminatedThis study tested a new drug called TAK-500, designed to activate the immune system to fight cancer. It was given alone or combined with an existing immunotherapy drug (pembrolizumab) to adults with advanced solid tumors that had stopped responding to standard treatments. The mai…
Matched conditions: ESOPHAGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC